One Trial at a Time
An operating system for Clinical Trial Design and Execution
Clinical trials are plagued by inefficiencies that cost billions and delay life-saving treatments
Manual iteration and resource-intensive workload. Critical data buried in massive information volumes.
Average cost to get a drug to market: $2.6B. Delays cost millions (Avg $40K/day in Phase 3).
Black-box decision making without audit trails. Volume of information means research isn't exhaustive.
Bias leading to regulatory and commercial failures. Design complexity causes failures and delays.
Complex workflows that don't engage ALL stakeholders lead to designs that can't be executed.
An operating system for trial cognition - bringing tech leadership and agentic intelligence to the clinical trial industry
Unifying clinical development and clinical operations in one comprehensive system that streamlines complex collaboration.
Breaking down silos between stakeholders with intelligent workflow automation and real-time collaboration tools.
Catalyzing coordinated execution through AI-powered insights and perspective-aware decision making.
Maximizing trial success by ensuring every voice is heard and every perspective is considered in the design process.
Domain expertise + Regulatory knowledge = Unbeatable moat
ChatGPT • Claude • LangChain • AutoGPT
While everyone fights over generic AI infrastructure, biotech sponsors win by owning purpose-built applications that competitors can't replicate
Multi-agent collaboration with built-in governance and perspective-aware reasoning
Mechanism of Action analysis and classification for drug compounds with intelligent tagging.
Regulatory alignment with GCP (Good Clinical Practice) validation and real-time compliance monitoring.
Statistical design with REML (Restricted Maximum Likelihood) and Bayesian optimization plugins.
Multi-perspective protocol evaluation across all stakeholder viewpoints with bias detection.
Context-rich documentation generation for protocols and regulatory submissions.
Real-time analytics and contextual insights for optimized trial design and execution.
Ontological Governance-Schema Protocol provides zero-trust credentialed access and complete audit trails for all agent interactions
A proven leadership combination of strategic execution and technical innovation
CEO & Co-Founder
Serial company builder with 25+ years scaling frontier innovations from lab to market. Yale biophysics, Harvard MBA, Naval Aviator, and Goldman Sachs veteran who raised $400M+ for regulated ventures. Disciplined risk management and institutional funding expertise.
Head of Product & Co-Founder
Engineering innovator and Harvard MBA with 20+ years pioneering data-driven solutions. Former Naval Submariner, Digital Gaia co-founder, and RMI Climate Intelligence architect. Specializes in translating complex systems into market-ready products.
Be among the first sponsor companies to transform protocol development from months to hours
Design Archetype Discovery pilot with your next protocol
Gain access to Copilot, MoA-Tagger, and Biostat Sidekick modules
Participate in OGSP credentialing and provide feedback on workflows
Collaborate on validation paper aligned to Forrester AI guidance
Influence AdjuvantIQ roadmap and feature priorities as founding partner
We're accepting only 25 founding partners for our initial pilot program. Join the companies already transforming their clinical development process.
Projected Year 5 ARR
Target SME Market
LTV/CAC Ratio